2026 Christopher E. Brightling: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	133	208	192	21	21	688	76193
Medicine	133	2188	2037	231	222	702	83952

Research.com Recognitions

Fellow of The Academy of Medical Sciences, United Kingdom
Fellow of The Academy of Medical Sciences, United Kingdom
Fellow of The Academy of Medical Sciences, United Kingdom
Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Christopher E. Brightling is affiliated with the University of Leicester in the United Kingdom. Their research primarily focuses on Medicine, with significant contributions to Pulmonary and Respiratory Medicine, Physiology, Neurology, Immunology, and Infectious Diseases.

The scientist has published extensively across frequent venues including:

European Respiratory Journal
American Journal of Respiratory and Critical Care Medicine
ERJ Open Research
bioRxiv (Cold Spring Harbor Laboratory)
The Lancet Respiratory Medicine

Key topics in their work cover a range of respiratory and immunological areas such as:

Asthma and respiratory diseases
Chronic Obstructive Pulmonary Disease (COPD) Research
Long-Term Effects of COVID-19
Respiratory and Cough-Related Research
IL-33, ST2, and ILC Pathways
COVID-19 Clinical Research Studies
Respiratory Support and Mechanisms

Notable recent papers include:

"Dexamethasone in Hospitalized Patients with Covid-19," 2020, published in DiRROS repository (University of Maribor)
"Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma," 2021, New England Journal of Medicine
"Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study," 2021, The Lancet Respiratory Medicine
"Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge," 2021, EClinicalMedicine
"Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes," 2021, European Respiratory Journal

Frequent co-authors include:

Neil Greening
Rachael A Evans
Louise V. Wain
Amisha Singapuri
Betty Raman

The scientist has been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

7892
Citations
Dexamethasone in Hospitalized Patients with Covid-19

P Horby;W S Lim;Emberson

7099
Citations
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush

4568
Citations
Cluster analysis and clinical asthma phenotypes.

Pranab Haldar;Ian D. Pavord;Dominic E. Shaw;Michael A. Berry

2414
Citations
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma

Pranabashis Haldar;Christopher E. Brightling;Beverley Hargadon;Sumit Gupta

2206
Citations
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

Ruth H Green;Christopher E Brightling;Susan McKenna;Beverley Hargadon

2203
Citations
Mast-Cell Infiltration of Airway Smooth Muscle in Asthma

Christopher E. Brightling;Peter Bradding;Fiona A. Symon;Stephen T. Holgate

1554
Citations
Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers

Mona Bafadhel;Susan McKenna;Sarah Terry;Vijay Mistry

1269
Citations
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

R H Green;C E Brightling;G Woltmann;D Parker

1109
Citations
Evidence of a role of tumor necrosis factor alpha in refractory asthma.

Mike A. Berry;Beverley Hargadon;Maria Shelley;Debbie Parker

1066
Citations
Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines

Richard S. Irwin;Michael H. Baumann;Donald C. Bolser;Louis Philippe Boulet

1062
Citations
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

Jean Bousquet;Jean Bousquet;Eva Mantzouranis;Alvaro A. Cruz;Nadia Aït-Khaled

998
Citations
Global Initiative for Asthma (GINA) Strategy 2021 – Executive summary and rationale for key changes

Helen K. Reddel;Helen K. Reddel;Leonard B. Bacharier;Leonard B. Bacharier;Eric D. Bateman;Eric D. Bateman;Christopher E. Brightling;Christopher E. Brightling

947
Citations
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

Andrew Menzies-Gow;Jonathan Corren;Arnaud Bourdin;Geoffrey Chupp

865
Citations
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial

Christopher E. Brightling;William Monteiro;Richard Ward;Debbie Parker

769
Citations
Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled Trial

Mona Bafadhel;Susan McKenna;Sarah Terry;Vijay Mistry

688
Citations
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

P Horby;W S Lim;J Emberson;M Mafham

674
Citations
Eosinophilic Bronchitis Is an Important Cause of Chronic Cough

Christopher E. Brightling;Richard Ward;Kah Lay Goh;Andrew J. Wardlaw

661
Citations
Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.

Hector G Ortega;Steven W Yancey;Bhabita Mayer;Necdet B Gunsoy

632
Citations
Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma

Mike Berry;Angela Morgan;Dominick E Shaw;Deborah Parker

629
Citations
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

Rachael A Evans;Hamish McAuley;Ewen M Harrison;Aarti Shikotra

624
Citations

Frequent Co-Authors

Ian D. Pavord University of Oxford

Andrew J. Wardlaw University of Leicester

Peter Bradding University of Leicester

Michael R. Barer University of Leicester

Liam G. Heaney Queen's University Belfast

Dave Singh University of Manchester

Robert Niven University of Manchester

Kian Fan Chung Imperial College London

Neil C. Thomson University of Glasgow

Martin D. Tobin University of Leicester

External Links

Personal website of Christopher E. Brightling

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring Immunology often leads students to related fields in healthcare, particularly nursing, where interdisciplinary knowledge is highly valued. For those interested in accelerating their nursing careers, accelerated RN to NP programs offer a fast-track route to becoming a nurse practitioner, combining advanced clinical skills with a solid foundation in immunological concepts.

If you're starting without a nursing background, consider online RN programs for non nurses in Florida, designed to accommodate learners transitioning into nursing from other fields. These programs emphasize flexibility and comprehensive training suited to immunology-related healthcare roles.

For individuals seeking a quicker entry into nursing, finding the easiest ABSN to get into can be a practical choice. These accelerated bachelor degree programs focus on essential nursing education, preparing students to contribute to immunological research and patient care swiftly.

Additionally, easy LPN programs to get into provide foundational nursing credentials with shorter timelines, catering to those who want to quickly enter the healthcare workforce and build experience that may later complement advanced studies in immunology.